Home The association of birthweight with maternal and cord serum and amniotic fluid growth hormone and insulin levels, and with neonatal and maternal factors in pregnant women who delivered at term
Article
Licensed
Unlicensed Requires Authentication

The association of birthweight with maternal and cord serum and amniotic fluid growth hormone and insulin levels, and with neonatal and maternal factors in pregnant women who delivered at term

  • Mehmet A. Osmanağaoğlu , Selen Osmanağaoğlu and Hasan Bozkaya
Published/Copyright: June 1, 2005
Journal of Perinatal Medicine
From the journal Volume 33 Issue 2

Abstract

Aim: To investigate the influence of maternal and cord serum and amniotic fluid growth hormone (GH) and insulin and other neonatal and maternal factors on birthweight.

Methods: A total of 160 pregnant women at 38–42 weeks' gestation were studied. All infants were categorized as small for gestational age (SGA) (n=50), large for gestational age (LGA) (n=50) or average for gestational age (AGA) (n=60). GH and insulin levels were measured in maternal and cord serum and amniotic fluid at birth.

Results: GH levels in maternal and cord serum and amniotic fluid showed no differences among the three weight groups (P>0.05). The cord insulin level was significantly lower in SGA (P<0.01). The insulin level in venous cord blood correlated with birth and placental weights and neonatal height, whereas maternal serum and amniotic fluid insulin levels, and maternal and cord serum and amniotic fluid GH levels did not show any correlation with birthweight. The cord GH level at birth was correlated with GH levels after 4 postnatal weeks in the SGA group (P<0.01). In addition, birthweight showed a correlation with prepartum maternal weight, maternal weight gain, maternal height, neonatal length and placental weight in all three weight groups.

Conclusions: Cord GH, maternal serum and amniotic fluid GH and insulin levels did not correlate with birthweight in all three weight groups. The lack of correlation for GH levels in maternal and cord serum and amniotic fluid suggests that these compartments may be non-communicating separate units.

:

Corresponding author: Mehmet A. Osmanağaoğlu, MD, Department of Obstetrics and Gynecology, Karadeniz Technical University, Faculty of Medicine, 61080 Trabzon/Turkey. Tel: +90-462-377-5419; Fax: +90-462-325-0518;

References

1 Albertsson-Wikland K, M Boguszewski MJ Karlberg: Children born small-for-gestational age: postnatal growth and hormonal status. Horm Res49 (1998) 7Search in Google Scholar

2 Caufriez A, F Frankenne, G Hennen, G Copinschi: Regulation of maternal IGF-I by placental GH in normal and abnormal human pregnancies. Am J Physiol265 (1993) 572Search in Google Scholar

3 Carpenter MW, JA Canick, JW Hogan, C Shellum, M Somers, JA Star: Amniotic fluid insulin at 14–20 weeks' gestation: association with later maternal glucose intolerance and birth macrosomia. Diabetes Care24 (2001) 1259Search in Google Scholar

4 Chellakooty M, K Vangsgaard, T Larsen, T Scheike, J Falck-Larsen, J Legarth, AM Andersson, KM Main, NE Skakkebaek, A Juul: A longitudinal study of intrauterine growth and the placental growth hormone (GH)-insulin-like growth factor I axis in maternal circulation: association between placental GH and fetal growth. J Clin Endocrinol Metab89 (2004) 384Search in Google Scholar

5 Clark PM, PC Hindmarsh, AW Shiell, CM Law, JW Honour, DJ Barker: Size at birth and adrenocortical function in childhood Clin Endocrinol (Oxf)45 (1996) 721Search in Google Scholar

6 Curran AJ, SR Peacey, SM Shalet: Is maternal growth hormone essential for a normal pregnancy? Eur J Endocrinol139 (1998) 54Search in Google Scholar

7 Cutfield WS, PL Hofman, M Vickers, B Breier, WF Blum, EM Robinson: IGFs and binding proteins in short children with intrauterine growth retardation J Clin Endocrinol Metab87 (2002) 235Search in Google Scholar

8 de Zegher F, M Vanderschueren-Lodeweyckx, B Spitz, Y Faijerson, F Blomberg, A Beckers, G Hennen, F Frankenne: Perinatal growth hormone (GH) physiology: effect of GH-releasing factor on maternal and fetal secretion of pituitary and placental GH J Clin Endocrinol Metab71 (1990) 520Search in Google Scholar

9 de Zegher F, I Francois, M van Helvoirt, G Van den Berghe: Clinical Review 89: small as fetus and short as child: from endogenous to exogenous growth hormone. J Clin Endocrinol Metab82 (1997) 2021Search in Google Scholar

10 Delmis J, A Drazancic, M Ivanisevic, E Suchanek: Glucose, insulin, HGH and IGF-I levels in maternal serum, amniotic fluid and umbilical venous serum: a comparison between late normal pregnancy and pregnancies complicated with diabetes and fetal growth retardation. J Perinat Med20 (1992) 47Search in Google Scholar

11 Evain-Brion D: Hormonal regulation of fetal growth. Horm Res42 (1994) 20710.1159/000184195Search in Google Scholar

12 Fowden AL: The role of insulin in prenatal growth. J Dev Physiol12 (1989) 173Search in Google Scholar

13 Gallaher BW, BH Breier, CL Keven, JE Harding, PD Gluckman: Fetal programming of insulin-like growth factor (IGF)-I and IGF-binding protein-3: Evidence for an altered response to undernutrition in late gestation following exposure to periconceptual undernutrition in the sheep. J Endocrinol159 (1998) 501Search in Google Scholar

14 Geffner ME: The growth without growth hormone syndrome. Endocrinol Metab Clin North Am25 (1996) 64910.1016/S0889-8529(05)70345-5Search in Google Scholar

15 Gluckman PD, AJ Gunn, A Wray, WS Cutfield, PG Chatelain, O Guilbaud, GR Ambler, P Wilton, K Albertsson-Wikland: Congenital idiopathic growth hormone deficiency associated with prenatal and early postnatal growth failure. The International Board of the Kabi Pharmacia International Growth Study. J Pediatr121 (1992) 920Search in Google Scholar

16 Gluckman PD: Clinical Review 68: The endocrine regulation of fetal growth in late gestation: the role of insulin-like growth factors. J Clin Endocrinol Metab80 (1995) 104710.1210/jc.80.4.1047Search in Google Scholar

17 Godfrey, KM, BH Breier, C Cooper: Constraint of the materno-placental supply of nutrients: Causes and consequences. In: O'Brien, PMS, T Wheeler, DJ Barker (eds): Fetal Programming: Influences on Development and Disease in Later Life. RCOG Press, London 1999Search in Google Scholar

18 Hall K, G Enberg, E Hellem, G Lundin, A Ottosson-Seeberger, V Sara, O Trygstad, U Ofverholm: Somatomedin levels in pregnancy: longitudinal study in healthy subjects and patients with growth hormone deficiency. J Clin Endocrinol Metab59 (1984) 587Search in Google Scholar

19 Harel Z, GS Tannenbaum: Long-term alterations in growth hormone and insulin secretion after temporary dietary protein restriction in early life in the rat. Pediatr Res38 (1995) 747Search in Google Scholar

20 Hokken-Koelega AC, MA De Ridder, RJ Lemmen, H Den Hartog, SM De Muinck Keizer-Schrama, SL Drop: Children born small for gestational age: do they catch up? Pediatr Res38 (1995) 267Search in Google Scholar

21 Ibanez L, N Potau, I Francois, F de Zegher: Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin Endocrinol Metab83 (1998) 3558Search in Google Scholar

22 Kaplan SL, MM Grumbach, TH Shepard: The ontogenesis of human fetal hormones. I. Growth hormone and insulin. J Clin Invest51 (1972) 3080Search in Google Scholar

23 Lesage C, J Walker, F Landier, P Chatelain, JL Chaussain, PF Bougneres: Near normalization of adolescent height with growth hormone therapy in very short children without growth hormone deficiency. J Pediatr119 (1991) 29Search in Google Scholar

24 Liu JP, J Baker, AS Perkins, EJ Robertson, A Efstratiadis: Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell75 (1993) 59Search in Google Scholar

25 Lubchenco LO, C Hansman, M Dressler, E Boyd: Intrauterine growth and estimated from live born birthweight data. Pediatrics32 (1963) 793Search in Google Scholar

26 McIntyre HD, R Serek, DI Crane, T Veveris-Lowe, A Parry, S Johnson, KC Leung, KK Ho, M Bougoussa, G Hennen, A Igout, FY Chan, D Cowley, A Cotterill, R Barnard: Placental growth hormone (GH), GH-binding protein, and insulin-like growth factor axis in normal, growth-retarded, and diabetic pregnancies: correlations with fetal growth. J Clin Endocrinol Metab85 (2000) 1143Search in Google Scholar

27 Spencer GS, GM Robinson, CJ Berry, PM Dobbie: Alteration of maternal growth hormone levels during pregnancy influences both fetal and postnatal growth in rats. Biol Neonate66 (1994) 112Search in Google Scholar

28 Thomson AM, WZ Billewicz, FE Hytten: The weight of the placenta in relation to birthweight. J Obstet Gynaecol Br Commonw76 (1969) 865Search in Google Scholar

29 Verhaeghe J, R Van Bree, E Van Herck, J Laureys, R Bouillon, FA Van Assche: C-Peptide, insulin-like growth factors I and II, and insulin-like growth factor binding protein-1 in umbilical cord serum: correlations with birth weight. Am J Obstet Gynecol169 (1993) 89Search in Google Scholar

30 von Muhlendahl KE, J Pachaly, M Schmidt-Gollwitzer: Lack of correlation between clinical data and growth hormone concentrations in cord blood. Biol Neonate29 (1976) 281Search in Google Scholar

31 Wu L, B Liu, S Yu: Correlation of intrauterine growth retardation with endocrine parameters. Zhonghua Fu Chan Ke Za Zhi 35 (2000) 26Search in Google Scholar

Published Online: 2005-06-01
Published in Print: 2005-03-01

©2005 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Declining fertility in the developed world and high maternal mortality in developing countries – how do we respond?
  2. Maternal obesity and complications during pregnancy
  3. Cesarean section upon request: is it appropriate for everybody?
  4. Reply to: Cesarean section upon request: is it appropriate for everybody?
  5. Characteristics of mothers who delivered the heaviest, average-weight, and lightest triplet sets
  6. Gestational age-specific distribution of twin birth weight discordance
  7. The comparison of amino-terminal probrain natriuretic peptide levels in preeclampsia and normotensive pregnancy
  8. Optimal timing for postprandial glucose measurement in pregnant women with diabetes and a non-diabetic pregnant population evaluated by the Continuous Glucose Monitoring System (CGMS®)
  9. Structural-tridimensional study of yolk sac in pregnancies complicated by diabetes
  10. Is cervical dilatation during parturition at term associated with apoptosis?
  11. Increased soluble VCAM-1 serum levels in preeclampsia are not correlated to urinary excretion or circadian blood pressure rhythm
  12. The association of birthweight with maternal and cord serum and amniotic fluid growth hormone and insulin levels, and with neonatal and maternal factors in pregnant women who delivered at term
  13. Amniotic fluid lamellar body counts for the determination of fetal lung maturity: an update
  14. Comparison of clinical criteria with echocardiographic findings in diagnosing PDA in preterm infants
  15. Sudden infant death syndrome “gray zone” disclosed only by a study of the brain stem on serial sections
  16. Incidence and diagnosis of unilateral arterial cerebral infarction in newborn infants
  17. Non-hydropic intrauterine fetal death more than 5 months after primary parvovirus B19 infection
  18. A new syndrome of myopathy with muscle spindle excess*
  19. Causes of left ventricular hypertrabeculation/non-compaction in a neonate and her mother
Downloaded on 2.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/JPM.2005.028/pdf
Scroll to top button